Silver Book Fact

A study looking at the effects of cardiovascular medicines in elderly patients who had previous heart attacks, found a total death rate reduction of 24% between 1995 and 2004.

Setoguchi S, Glynn R, Avorn J, Mittleman M, et al. Improvements in Long-Term Mortality After Myocardial Infarction and Increased Use of Cardiovascular Drugs After Discharge: A 10-year trend analysis. JACC. 2008; 51(13): 1247-54. http://content.onlinejacc.org/cgi/content/abstract/51/13/1247?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&author1=Setoguchi&fulltext=Improvements+in+long-term+mortality&andorexactfulltext=and&searchid=1&FIRSTINDEX=0&sortspec=relevance&resourcetype=HW

Reference

Title
Improvements in Long-Term Mortality After Myocardial Infarction and Increased Use of Cardiovascular Drugs After Discharge: A 10-year trend analysis
Publication
JACC
Publication Date
2008
Authors
Setoguchi S, Glynn R, Avorn J, Mittleman M, et al
Volume & Issue
Volume 51, Issue 13
Pages
1247-54
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • For every dollar spent on cardiovascular medical treatments, a return of $4 is realized.  
  • Every additional dollar spent on the overall treatment of stroke has produced health gains valued at $1.55.  
  • About 70% of the survival improvement in heart attack mortality resulted from changes in technology.  
  • TAVR v. SAVR in Intermediate-Risk SAS Patients
    At 1-year, severe aortic stenosis (SAS) patients with intermediate surgical mortality risk who underwent transcatheter aortic valve replacement (TAVR), had all-cause mortality rates of 7.4% (compared to 13% for surgical…  
  • A recent data analysis of more than 2,700 stroke patients from the U.S. and Europe confirmed tPA’s effectiveness, which could save the U.S. nearly $50 million a year.